NCT04747418View on ClinicalTrials.gov

Uterine Inflammatory Characteristics

CompletedOBSERVATIONAL
Enrollment

163

Participants

Timeline

Start Date

February 1, 2021

Primary Completion Date

April 7, 2025

Study Completion Date

April 7, 2025

Conditions
Cesarean Section ComplicationsFertility Disorders
Interventions
PROCEDURE

Diagnostic Hysteroscopy

Collection of first 5 cc of normal saline from the output port during diagnostic hysteroscopy

PROCEDURE

Trans-vaginal ultrasound

Trans vaginal ultrasound performed immediately following the diagnostic hysteroscopy ( as sonohysterography)

Trial Locations (1)

Unknown

Sheba Medical Center, Ramat Gan

All Listed Sponsors
lead

Sheba Medical Center

OTHER_GOV

NCT04747418 - Uterine Inflammatory Characteristics | Biotech Hunter | Biotech Hunter